Safety Alerts

In addition to a full suite of medication safety newsletters for healthcare professionals and consumers, ISMP makes available urgent medication advisories. These Safety Alerts address serious medication errors or information requiring immediate attention by healthcare practitioners.

ISMP Alerts

ISMP collects and analyzes thousands of medication error and adverse event reports each year, including through its voluntary ISMP National Medication Errors Reporting Program (ISMP MERP), National Vaccine Errors Reporting Program (ISMP VERP), and consumer medication error reporting program (ISMP C-MERP). ISMP issues alerts through its many communication channels to share emerging information on errors happening across the nation, “lessons learned,” and prevention strategies with the entire healthcare community.

NAN Alerts

Beginning in 2009, ISMP joined the American Society of Health-System Pharmacists (ASHP) and other members of the National Coordinating Council on Medication Error Reporting and Prevention (NCC MERP) to create a National Alert Network (NAN). The NAN warns healthcare providers through several national distribution channels about actual or potential medication errors that have recently caused serious harm or death. The alerts are based on information submitted to the ISMP MERP.

FDA Alerts

Periodically, the US Food and Drug Administration (FDA) issues alerts related to medication recalls, increased incidence of adverse events for certain medications, and recommendations for reducing naming or packaging errors.

PSA Advisories

The Pennsylvania Patient Safety Authority (PSA) publishes a quarterly advisory to provide additional guidance on specific issues related to distribution and use of medications.

Filter by type
Fresenius Kabi USA is voluntarily recalling lot 6400048 (expires July 2018) of Midazolam Injection, USP, 2 mg/2 mL packaged in...